Related Experiment Video
Updated: Jun 16, 2026

09:43
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Epstein-Barr virus-associated diffuse large B-cell lymphoma arising on cardiac prostheses
Dylan V Miller1, Dennis J Firchau, Rebecca F McClure
1Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USa. dylan.miller@imail.org
The American Journal of Surgical Pathology
|February 9, 2010
Summary
Primary cardiac lymphoma is extremely rare, with only three reported cases involving prosthetic valves. This study details three new cases of diffuse large B-cell lymphoma (DLBCL) in prosthetic cardiac devices, suggesting potential for better prognosis due to resectability.
Area of Science:
- Cardiovascular Pathology
- Hematologic Oncology
- Prosthetic Device Infections
Background:
- Primary cardiac lymphoma is exceptionally rare.
- Lymphoma associated with prosthetic heart valves is exceedingly uncommon, with only 3 prior case reports.
- Diffuse large B-cell lymphoma (DLBCL) can involve cardiac prosthetics.
Observation:
- Three patients presented with DLBCL involving prosthetic heart valves and a synthetic tube graft.
- Histological examination revealed tumor lymphocytes on the luminal surface of prosthetic materials with fibrinous debris.
- All cases exhibited a nongerminal center B-cell phenotype and were Epstein-Barr virus positive.
Findings:
- The described cases align with the 2008 World Health Organization criteria for DLBCL associated with chronic inflammation.
- No distant disease or recurrence was noted after surgical removal of the affected prostheses.
- The tumor lymphocytes demonstrated frequent mitoses and abundant karyorrhectic debris.
Implications:
- Surgical resectability of cardiac DLBCL in prosthetic devices may confer a more favorable prognosis compared to similar entities at other sites.
- This study expands the understanding of rare cardiac lymphomas.
- Further research is warranted to confirm the prognostic implications of resectability in cardiac DLBCL.